Role of Mucus in EHEC colonization of human colonoids and intestinal disease devleopment
Role of Mucus in EHEC colonization of human colonoids and intestinal disease devleopment
批准号:
9351785
负责人:
OLGA KOVBASNJUK
金额:
$14.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-23 至 2017-08-31
关键词:
Adherent CultureAdoptedAffectAnimal ModelAntibioticsApicalBacteriaBindingBiological AssayBiopsyCell CommunicationCell LineCessation of lifeCleaved cellClinical DataColonComplexDataDevelopmentDiarrheaDiseaseDistalEnergy-Generating ResourcesEnteralEnzymesEpithelialEpithelial AttachmentEpithelial CellsEpitheliumEscherichia coli EHECEscherichia coli InfectionsFaceFlagellaGoalsGrantHemolytic-Uremic SyndromeHemorrhagic colitisHospitalizationHumanIn VitroInfectionIntestinal DiseasesIntestinesLifeMediatingMedicalModelingMolecularMucin-2 Staining MethodMucinsMucous body substanceOryctolagus cuniculusPathogenesisPathologyPatientsPhasePlayProductionRiskRoleSeptic ToxemiaShiga ToxinSiteStagingStem cellsSurfaceSystemic diseaseTechnologyTestingThickTimeToxinVirulenceVirulence FactorsWorkadult stem cellbasecolon cancer cell lineeffective therapyenteric pathogenfoodbornehuman stem cellshuman subjectimprovedindividual patientinsightintestinal epitheliummicrobialmonolayermutantnew therapeutic targetnovelnovel therapeutic interventionresearch studystem cell biologysugartherapeutic targetuptake
中文摘要
总结
英文摘要
Summary
The proposed work will advance understanding of enteric disease caused by food-borne, Shiga-toxin-
producing enterohemorrhagic E. coli (EHEC) constitute the major US cause of life-threatening hemorrhagic
colitis and hemolytic uremic syndrome (HUS). While shiga toxin 2a provides the main virulence factor for
intestinal and extra-intestinal disease manifestations, clinical data strongly suggest that Stx-toxemia occurs
early in illness and is short-lived. We thus focus on early EHEC-host interactions, especially the complex
interactions between EHEC and intestinal mucus. Intestinal mucus represents the first line of defense against
enteric pathogens and is the first site for the interaction of EHEC with the human colonic epithelium. Our
exciting preliminary data suggest that mucus play an important role in EHEC colonization of the human colon.
These data were obtained using a novel model of EHEC infection, termed human colonoids, which are primary
colonic epithelial cultures derived from adult stem cells isolated from biopsies of healthy donors. Upon
differentiation, human colonoids produce a thick layer of mucus similar to that which is normally present in the
human colon. EHEC infection results in the destruction of the mucus layer allowing EHEC to gain access to the
colonocyte surface. These data suggest that human colonoids recapitulate EHEC infection and provide unique
insights into pathogenesis that differ from other studies performed in human colon cancer cell lines, allowing
improved appreciation of the roles of virulence factors and assessment of novel therapeutic targets. We
hypothesize that EHEC interaction with colonic mucus is a necessary step in initial colonization of colonic
epithelium leading to Stx production and full manifestation of intestinal disease. To test this hypothesis, we
propose to use two complementary models of EHEC infection: human colonoids and the rabbits, which is the
best animal model that can recapitulate EHEC-induced human intestinal pathologies, including hemorrhagic
colitis, to achieve the following Aims: 1. Determine whether mucus degradation by EHEC is necessary to
colonize the human epithelium. 2. Determine whether direct interaction between EHEC flagella and mucin(s)
provides an initial anchor for EHEC-colonocyte attachment. 3. Determine whether the interaction of EHEC with
mucus affects the production and release of the major EHEC virulence factor, Stx2a. The results gained from
the proposed experiments will further elucidate the molecular mechanisms for EHEC interactions with human
colonic epithelium, particularly the mucus layer, and establish the role of mucus in EHEC pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiphoton Laser Scanning Microscope: Zeiss LSM710 NLO
-
批准号:7793075
-
项目类别:
-
资助金额:$49.85万
-
财政年份:2010
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Shiga toxin uptake mechanisms and intracellular action
-
批准号:7934544
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2009
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Shiga toxin uptake mechanisms and intracellular action
-
批准号:7654068
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2009
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Zeiss 510/META Confocal Microscope Plus Live Cell Chamber
-
批准号:7216564
-
项目类别:
-
资助金额:$44.42万
-
财政年份:2007
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Two-Photon Microscopy Imaging Core
-
批准号:7487974
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2007
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Two-Photon Microscopy Imaging Core
-
批准号:7133534
-
项目类别:
-
资助金额:$9.16万
-
财政年份:2006
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Shiga toxin 1:uptake mechanisms and intracellular action
-
批准号:6799566
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2003
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Shiga toxin 1:uptake mechanisms and intracellular action
-
批准号:6680759
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2003
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Shiga toxin 1:uptake mechanisms and intracellular action
-
批准号:6935381
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2003
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Core B-Imaging
-
批准号:9279104
-
项目类别:
-
资助金额:$21.3万
-
财政年份:--
-
负责人:OLGA KOVBASNJUK
-
依托单位:
Two-Photon Microscopy Imaging Core
-
批准号:7675274
-
项目类别:
-
资助金额:$9.11万
-
财政年份:--
-
负责人:OLGA KOVBASNJUK
-
依托单位:
海外基金